Segall Bryant & Hamill, LLC Axonics, Inc. Transaction History

Segall Bryant & Hamill, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$66.47 - $69.65 $1.02 Million - $1.07 Million	-15,391 Reduced 27.11%	41,388 $2.78 Million
Q1 2024 May 15, 2024	SELL	$56.67 - $69.36 $583,757 - $714,477	-10,301 Reduced 15.36%	56,779 $3.92 Million
Q4 2023 Feb 14, 2024	BUY	$49.38 - $63.75 $460,666 - $594,723	9,329 Added 16.15%	67,080 $4.17 Million
Q3 2023 Nov 09, 2023	BUY	$48.64 - $62.51 $2.81 Million - $3.61 Million	57,751 New	57,751 $3.24 Million

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.